[
 {
  "title": "Brain Biology and Cognitive Impairment",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Research is being conducted on brain lipid utilization in the context of finding preventative measures for cognitive impairment, specifically Alzheimer’s disease (AD). This involves understanding the architecture and energy systems of the brain, and what these systems look like when something goes wrong and cognitive decline ensues.",
  "content_length": 334,
  "content_tokens": 57,
  "embedding": []
 },
 {
  "title": "ApoE Genotype and Alzheimer’s Disease",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The evolutionary origins of the ApoE genotype, with specific attention to the ApoE4 allele and its association with AD, are being studied. The implications of ApoE4 for the brain’s fuel utilization, notably omega-3 fatty acids: EPA and DHA, are being explored.",
  "content_length": 260,
  "content_tokens": 63,
  "embedding": []
 },
 {
  "title": "Omega-3 Fatty Acids and Brain Health",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The implications of recent omega-3 trials for cardiovascular disease and what we currently understand about EPA/DHA and brain health are being discussed. Potential dietary interventions across the lifespan to preserve and prolong cognitive function are being contemplated.",
  "content_length": 272,
  "content_tokens": 44,
  "embedding": []
 },
 {
  "title": "Apolipoprotein E (ApoE) Structure and Function",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The structure and function of Apolipoprotein E (ApoE) in the periphery and its function in the brain are being studied. The evolutionary origins of ApoE isoforms and the ApoE4 variant and Alzheimer’s Disease (AD) risk are being explored.",
  "content_length": 237,
  "content_tokens": 58,
  "embedding": []
 },
 {
  "title": "Dietary Fuel Preference and Omega-3 Fatty Acids",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The dietary fuel preference with the ApoE4 allele and the role of omega-3 fatty acids in the brain are being researched. The relationship between dietary omega-3 intake and brain health is being studied.",
  "content_length": 203,
  "content_tokens": 42,
  "embedding": []
 },
 {
  "title": "Preventing Cognitive Decline",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Research is being conducted on a critical window for DHA in ApoE4 carriers to prevent cognitive decline. Ongoing research and recommendations for E4 carriers are being developed.",
  "content_length": 178,
  "content_tokens": 35,
  "embedding": []
 },
 {
  "title": "Optimizing Brain Health",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Alzheimer's disease including the possibility of a vascular hypothesis as well as the factors that can impact disease risk such as type 2 diabetes, blood pressure, omega supplementation, exercise, sauna, and more. The breakdown of the blood-brain barrier in neurodegenerative disease. An explanation for the observation that type 2 diabetes increases risk of Alzheimer’s disease. The role of omega-3 fatty acids (EPA and DHA) in brain health and prevention of neurodegeneration. Blood pressure: an important modifiable lifestyle factor that can affect Alzheimer's disease risk. Possible mechanisms by which exercise reduces the risk of Alzheimer’s disease. Possible brain benefits of sauna. The relationship between cardiorespiratory fitness and dementia risk. How exercise may reduce the risk of cancer. Impact of alcohol consumption on breast cancer risk and overall health. Exercise as an intervention for poor sleep habits. The longevity benefits of consuming adequate protein and strength training to preserve muscle mass and strength. How to get enough of the right kind of protein in your diet. Fasting: weighing the risk vs. reward.",
  "content_length": 1140,
  "content_tokens": 223,
  "embedding": []
 },
 {
  "title": "Brain Composition and Function",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The brain is composed of 3 main types of cells: neurons, glial cells, and microglial cells. The brain is a unique compartment that is mostly lipid and contains a large amount of lipids—from sterols to different forms of fatty acids. The brain is surrounded by the blood-brain barrier which separates the blood vessels and the blood inside the blood vessels from the brain. Cerebral spinal fluid (CSF) is the “sewage system” of the brain and allows drainage from the brain cells, from the interstitial fluid. The brain is a bloodless organ and is an electrical system that requires lipids. Cells of the brain require lipid and cholesterol. The brain’s function is signal transduction and requires “electricity” that moves within the neuronal map; requires lipids.",
  "content_length": 762,
  "content_tokens": 167,
  "embedding": []
 },
 {
  "title": "Brain Energy Utilization",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The way the brain utilizes energy represents a knowledge gap in the field. The brain regulates glucose content but is not dependent on insulin signalling. The rest of the body regulates transporter via insulin that acts with GLUT4 which allows an insulin-dependent mechanism to enter glucose into pumping muscles or adipocytes.",
  "content_length": 327,
  "content_tokens": 59,
  "embedding": []
 },
 {
  "title": "GLUT4 Expression and Regulation",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "You can induce GLUT4 expression by exercising or by the changes in body weight. It responds to the external environment.",
  "content_length": 120,
  "content_tokens": 24,
  "embedding": []
 },
 {
  "title": "Blood-Brain Barrier and GLUT1",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The blood-brain barrier uses GLUT1 predominantly, which is regulated by the peripheral glucose concentration. In type 2 diabetes, where there is systemic hyperglycemia, the brain protects itself by reducing GLUT1 expression at the blood-brain barrier. During a prolonged fast and the system is hypoglycemic, the brain upregulates GLUT1 at the blood-brain barrier to extract glucose from circulation.",
  "content_length": 399,
  "content_tokens": 83,
  "embedding": []
 },
 {
  "title": "Brain's Fuel Preference",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The brain prefers glucose instead of fat. When glucose is not available, the brain extracts ketone bodies produced by fatty acid oxidation in the peripheral system. Neuron prefers lactate over glucose. Astrocytes take up glucose and produce lactate, 'donating' the lactate to the neuron.",
  "content_length": 287,
  "content_tokens": 60,
  "embedding": []
 },
 {
  "title": "Apolipoprotein E (ApoE) Structure and Function",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "ApoE has many roles in the circulatory system. It has two arms: the N-terminus binds to the receptor and the C-terminus is embedded inside the lipid core of the lipoprotein particle. The mutation of ApoE4 which substitutes the cystine with the arginine changes how ApoE folds and unfolds.",
  "content_length": 288,
  "content_tokens": 72,
  "embedding": []
 },
 {
  "title": "ApoE Function in the Brain",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "In the brain there are no LDL, VLDL, HDL but there are Apo lipoprotein particles. ApoE in the brain is not facilitating clearance of lipids or the rate by which lipolysis is happening. Its role in the brain is largely supporting the astrocytes. For astrocytes to support neurons they need to efficiently crosstalk, facilitated by ApoE diverse functions.",
  "content_length": 353,
  "content_tokens": 86,
  "embedding": []
 },
 {
  "title": "ApoE4 Variant and Alzheimer’s Disease Risk",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "ApoE4 became a predictor of AD in the late 1980’s. Two copies of ApoE4 increases AD 12-fold. One copy of E4 will increase AD chance between 2- to 4-fold. ApoE2 is thought to be protective against getting AD.",
  "content_length": 207,
  "content_tokens": 60,
  "embedding": []
 },
 {
  "title": "Dietary Fuel Preference with the ApoE4 Allele",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "ApoE4 carrier risk for AD is based on an age model. There is a subset of those who are aging and getting disease. E4 carriers are less capable of regulating fuel modulation mechanisms including GLUT1. E4 makes GLUT1 less successful at the blood-brain barrier. ApoE4 transmits risk of disease through an energy crisis.",
  "content_length": 317,
  "content_tokens": 73,
  "embedding": []
 },
 {
  "title": "Leaky Blood-Brain Barrier and Health",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The blood-brain barrier allowing toxins to get into the brain and shrink cells is being investigated. This loss of integrity in the blood-brain barrier is a health concern.",
  "content_length": 172,
  "content_tokens": 34,
  "embedding": []
 },
 {
  "title": "Role of Omega-3 Fatty Acids in Brain Health",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The brain is largely composed of polyunsaturated fatty acids (PUFA), including omega-3 fatty acids such as docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and alpha-linoleic acid (ALA). These PUFAs facilitate neuronal firing and allow the brain to work efficiently. The human body cannot make DHA/EPA from scratch, so they must come from the diet. However, the standard diet may not provide enough omega-3’s to the brain, potentially contributing to disease pathogenesis.",
  "content_length": 480,
  "content_tokens": 117,
  "embedding": []
 },
 {
  "title": "Omega-3 Deficiency and Disease Risk",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Omega-3 deficiency may increase the risk of disease. This deficiency state can predispose a person to disease. Smaller studies suggest ramifications later on if omega-3 deficient at an early age, such as subtle cognitive impairments, anxiety disorders, mood disorders, and depression.",
  "content_length": 284,
  "content_tokens": 56,
  "embedding": []
 },
 {
  "title": "Preventing Cognitive Decline: DHA in ApoE4 Carriers",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Research suggests that there may be a critical window for DHA in ApoE4 carriers to prevent cognitive decline. At a certain age, the ability of the ApoE4 brain to capture fatty acids from blood gets compromised. This happens around the same time that the GLUT1 receptors are compromised, when the blood-brain barrier itself starts to get compromised. A randomized clinical trial evaluated patients with mild Alzheimer’s disease given 2g/d of DHA versus placebo over a 15-month period reported no effect on cognitive impairment.",
  "content_length": 526,
  "content_tokens": 109,
  "embedding": []
 },
 {
  "title": "Ongoing Research and Recommendations for E4 Carriers",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Current research is investigating how older E4 carriers assimilate supplemental DHA and whether it can prevent cognitive decline. The study is focusing on a cohort aged 55 to 70 years old. The results of this study could provide valuable insights into the prevention of cognitive decline and Alzheimer's disease.",
  "content_length": 312,
  "content_tokens": 56,
  "embedding": []
 },
 {
  "title": "Brain Health and Dementia",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "In an older brain, once dementia starts there is a failure to utilize glucose as a source of energy and phospholipase enzymes that facilitate cellular auto-digestion are upregulated. The enzyme is activated in the brain to possibly extract FAs for its own neuronal myelin to produce ATP. Phospholipase A2 enzyme (PLA2) control omega-3 and omega-6 FA utilization in the brain. Calcium-dependent enzyme of phospholipase A2 is strongly upregulated in AD disease brains. The effect is neuronal inflammation and oxidative stress.",
  "content_length": 524,
  "content_tokens": 116,
  "embedding": []
 },
 {
  "title": "Dietary Interventions and Disease",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Once carriers have disease there is likely less benefit from ketone supplementation compared to non-carriers. The largest studies to date do not demonstrate beneficial response to supplementation once carriers have disease. The degenerating blood brain barrier compromising the transport of ketone bodies, the same way it has compromised glucose and omega-3 FAs. Dietary interventions at this stage may not be very effective. Highlights the importance of getting the right intervention before you get to that stage.",
  "content_length": 515,
  "content_tokens": 91,
  "embedding": []
 },
 {
  "title": "Omega-3 and Cognitive Outcomes",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "It is recommended that people have at least 1 serving of fatty fish per week. Epidemiology studies suggest that carriers who consume 1 serving of fatty fish per week may be providing enough omega-3s to the brain to help mitigate disease longer-term. The best advice is to maintain adequate omega-3 consumption from fatty fish and not supplements and to control blood pressure and exercise throughout the lifespan.",
  "content_length": 413,
  "content_tokens": 78,
  "embedding": []
 },
 {
  "title": "Exercise and Cognitive Decline",
  "date": "February 1, 2021",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Exercise may help mitigate cognitive decline. PET imaging study reports that carriers who exercise have less amyloid plaque buildup compared to carriers who did not exercise. Multiple factors including high level of education and hypertension control protected carriers from dementia.",
  "content_length": 284,
  "content_tokens": 46,
  "embedding": []
 }
]